{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:01:16Z","timestamp":1785564076936,"version":"3.56.0"},"reference-count":51,"publisher":"Japan Society of Plastic and Reconstructive Surgery","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPRS"],"published-print":{"date-parts":[[2026,7,27]]},"DOI":"10.53045\/jprs.2025-0068","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T22:08:37Z","timestamp":1763676517000},"page":"265-273","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and Treatment Outcomes of Voriconazole-Induced Invasive Cutaneous Squamous Cell Carcinoma in Japanese Patients with Pulmonary Aspergillosis"],"prefix":"10.53045","volume":"5","author":[{"given":"Yoshiro","family":"Abe","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Tokushima University Graduate School of Biomedical Sciences"},{"name":"Department of Plastic and Reconstructive Surgery, University of Occupational and Environmental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Mineda","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Mizuguchi","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Ikushima","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"31107","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002 Aug; 347 (6): 408-15.","DOI":"10.1056\/NEJMoa020191"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sol\u00e9 A. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B. Int J Antimicrob Agents. 2008 Nov; 32 (suppl 2): S161-5.","DOI":"10.1016\/S0924-8579(08)70019-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bow EJ. Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients. Med Mycol. 2005 May; 43 (suppl 1): S277-87.","DOI":"10.1080\/13693780400019990"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Husain S, Paterson DL, Studer S, et al. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant. 2006 Dec; 6 (12): 3008-16.","DOI":"10.1111\/j.1600-6143.2006.01548.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cadena J, Levine DJ, Angel LF, et al. Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness. Am J Transplant. 2009 Sep; 9 (9): 2085-91.","DOI":"10.1111\/j.1600-6143.2009.02734.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wingard JR, Carter SL, Walsh TJ, et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood. 2010 Dec 9; 116 (24): 5111-8.","DOI":"10.1182\/blood-2010-02-268151"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic\/pharmacodynamic profile of voriconazole. Clin Pharmacokinet. 2006; 45 (7): 649-63.","DOI":"10.2165\/00003088-200645070-00002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Williams K, Mansh M, Chin-Hong P, et al. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients. Clin Infect Dis. 2014 Apr; 58 (7): 997-1002.","DOI":"10.1093\/cid\/cit940"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hamandi B, Fegbeutel C, Silveira FP, et al. Voriconazole and squamous cell carcinoma after lung transplantation: a multicenter study. Am J Transplant. 2018 Jan; 18 (1): 113-24.","DOI":"10.1111\/ajt.14500"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ramsay HM, Fryer AA, Reece S, et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis. 2000 Jul; 36 (1): 167-76.","DOI":"10.1053\/ajkd.2000.8290"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. O'Reilly Zwald F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011 Aug; 65 (2): 253-61.","DOI":"10.1016\/j.jaad.2010.11.062"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vadnerkar A, Nguyen MH, Mitsani D, et al. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients. J Heart Lung Transplant. 2010 Nov; 29 (11): 1240-4.","DOI":"10.1016\/j.healun.2010.05.022"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zwald FO, Spratt M, Lemos BD, et al. Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation. Dermatol Surg. 2012 Aug; 38 (8): 1369-74.","DOI":"10.1111\/j.1524-4725.2012.02418.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Feist A, Lee R, Osborne S, et al. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole. J Heart Lung Transplant. 2012 Nov; 31 (11): 1177-81.","DOI":"10.1016\/j.healun.2012.05.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Singer JP, Boker A, Metchnikoff C, et al. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients. J Heart Lung Transplant. 2012 Jul; 31 (7): 694-9.","DOI":"10.1016\/j.healun.2012.02.033"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002 Jul; 47 (1): 1-18.","DOI":"10.1067\/mjd.2002.125579"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bouwes Bavinck JN, Euvrard S, Naldi L, et al. Keratotic skin lesions, and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in the Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol. 2007 Jul; 127 (7): 1647-56.","DOI":"10.1038\/sj.jid.5700776"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lindel\u00f6f B, Jarnvik J, Ternesten-Bratel A, et al. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort. Acta Derm Venereol. 2006; 86 (3): 219-22.","DOI":"10.2340\/00015555-0069"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Epaulard O, Villier C, Ravaud P, et al. A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study. Clin Infect Dis. 2013 Dec; 57 (12): e182-8.","DOI":"10.1093\/cid\/cit600"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. D'Arcy ME, Pfeiffer RM, Rivera DR, et al. Voriconazole and the risk of keratinocyte carcinomas among lung transplant recipients in the United States. JAMA Dermatol. 2020 Jul 1; 156 (7): 772-9.","DOI":"10.1001\/jamadermatol.2020.1141"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chung CL, Nadhan KS, Shaver CM, et al. Comparison of posttransplant dermatologic diseases by race. JAMA Dermatol. 2017 Jun; 153 (6): 552-8.","DOI":"10.1001\/jamadermatol.2017.0045"},{"key":"22","unstructured":"22. Donations in 2023 [Internet]. International registry in organ donation and transplantation (IRODaT). 2024 Dec [cited 2025 Apr 11]. Available from: https:\/\/www.irodat.org\/img\/database\/grafics\/2023_01_worldwide-actual-deceased-organ-donors.png"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Patel AR, Turner ML, Baird K, et al. Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2009 Mar; 15 (3): 370-6.","DOI":"10.1016\/j.bbmt.2008.12.491"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sawada Y, Nakai Y, Yokota N, et al. Voriconazole-induced squamous cell carcinoma after hematopoietic stem cell transplantation showing early-stage vascular invasion. Dermatopathology (Basel). 2020 Oct 9; 7 (3): 48-52.","DOI":"10.3390\/dermatopathology7030008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tanaka H, Okuma M, Ishii T. Occurrence of voriconazole-induced cutaneous squamous cell carcinoma in Japan: data mining from different national pharmacovigilance databases. Pharmazie. 2022 Oct 1; 77 (10): 307-10.","DOI":"10.31083\/ph.2022.2453"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nobeyama Y, Umezawa Y, Asahina A. Risk of squamous cell carcinoma in immunosuppressed patients with voriconazole-related actinic keratosis. J Dermatol. 2022 Nov; 49 (11): 1168-72.","DOI":"10.1111\/1346-8138.16552"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2017. 272 p.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988 Jun; 124 (6): 869-71.","DOI":"10.1001\/archderm.1988.01670060015008"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Epaulard O, Leccia MT, Blanche S, et al. Phototoxicity and photocarcinogenesis associated with voriconazole. Med Mal Infect. 2011 Dec; 41 (12): 639-45.","DOI":"10.1016\/j.medmal.2011.09.016"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Du L, Hoffman SM, Keeney DS. Epidermal CYP2 family cytochromes P450. Toxicol Appl Pharmacol. 2004 Mar; 195 (3): 278-87.","DOI":"10.1016\/j.taap.2003.09.020"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Swanson HI. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. Chem Biol Interact. 2004 Oct; 149 (2-3): 69-79.","DOI":"10.1016\/j.cbi.2004.08.006"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Murayama N, Imai N, Nakane T, et al. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes. Biochem Pharmacol. 2007 Jun; 73 (12): 2020-6.","DOI":"10.1016\/j.bcp.2007.03.012"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ona K, Oh DH. Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A. Br J Dermatol. 2015 Sep; 173 (3): 751-9.","DOI":"10.1111\/bjd.13862"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ikeya S, Sakabe JI, Yamada T, et al. Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation. Sci Rep. 2018 Mar 22; 8 (1): 5050.","DOI":"10.1038\/s41598-018-23439-7"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shimizu T, Ochiai H, Asell F, et al. Bioinformatics research on inter-racial difference in drug metabolism I. Analysis on frequencies of mutant alleles and poor metabolizers on CYP2D6 and CYP2C19. Drug Metab Pharmacokinet. 2003; 18 (1): 48-70.","DOI":"10.2133\/dmpk.18.48"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Ishihara K, Saida T, Otsuka F, et al. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol. 2008 Feb; 13 (1): 33-41.","DOI":"10.1007\/s10147-007-0751-1"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Umezono Y, Sato Y, Noto M, et al. Incidence rate of cutaneous squamous cell carcinoma is rapidly increasing in Akita Prefecture: urgent alert for super-aged society. J Dermatol. 2019 Mar; 46 (3): 259-62.","DOI":"10.1111\/1346-8138.14759"},{"key":"38","unstructured":"38. Ishihara K. Statistics for skin cancers caused by ultraviolet radiation. Biol Ther. 2005 Sep; 19 (5): 411-6."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Nguyen KD, Han J, Li T, et al. Invasive cutaneous squamous cell carcinoma incidence in US health care workers. Arch Dermatol Res. 2014 Aug; 306 (6): 555-60.","DOI":"10.1007\/s00403-014-1469-3"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Flohil SC, van der Leest RJ, Dowlatshahi EA, et al. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol. 2013 Aug; 133 (8): 1971-8.","DOI":"10.1038\/jid.2013.134"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Moloney FJ, Kelly PO, Kay EW, et al. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol Surg. 2004 Apr; 30 (4 Pt 2): 674-8.","DOI":"10.1111\/j.1524-4725.2004.00155.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Ca\u00f1ueto J, Mart\u00edn-Vallejo J, Carde\u00f1oso-\u00c1lvarez E, et al. Rapid growth rate is associated with poor prognosis in cutaneous squamous cell carcinoma. Clin Exp Dermatol. 2018 Dec; 43 (8): 876-82.","DOI":"10.1111\/ced.13570"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Euvrard S, Kanitakis J, Decullier E, et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation. 2006 Apr; 81 (8): 1093-100.","DOI":"10.1097\/01.tp.0000209921.60305.d9"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Motley R, Kersey P, Lawrence C, et al. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2002 Jan; 146 (1): 18-25.","DOI":"10.1046\/j.0007-0963.2001.04615.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Khan AA, Potter M, Cubitt JJ, et al. Guidelines for the excision of cutaneous squamous cell cancers in the United Kingdom: the best cut is the deepest. J Plast Reconstr Aesthet Surg. 2013 Apr; 66 (4): 467-71.","DOI":"10.1016\/j.bjps.2012.12.016"},{"key":"46","unstructured":"46. Mohs FE. Chemosurgery: a method for the microscopically controlled excision of cancer of the skin and lips. Geriatrics. 1959 Feb; 14 (2): 78-88."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Suzuki S, Kim SI, Barlow TK. Barriers to Mohs micrographic surgery in Japanese patients with basal cell carcinoma. Cutis. 2024 Jul; 114 (1): E16-20.","DOI":"10.12788\/cutis.1057"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys. 2004 Oct; 60 (2): 406-11.","DOI":"10.1016\/j.ijrobp.2004.03.006"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Epaulard O, Saint-Raymond C, Villier C, et al. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients. Clin Microbiol Infect. 2010 Sep; 16 (9): 1362-4.","DOI":"10.1111\/j.1469-0691.2009.03124.x"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Wong TY, Loo YS, Veettil SK, et al. Efficacy and safety of posaconazole for the prevention of invasive fungal infections in immunocompromised patients: a systematic review with meta-analysis and trial sequential analysis. Sci Rep. 2020 Sep; 10 (1): 14575.","DOI":"10.1038\/s41598-020-71571-0"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Auberger J, Lass-Fl\u00f6rl C, Aigner M, et al. Invasive fungal breakthrough infections, fungal colonization, and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother. 2012 Sep; 67 (9): 2268-73.","DOI":"10.1093\/jac\/dks189"}],"container-title":["Journal of Plastic and Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jprs\/5\/4\/5_2025-0068\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T05:29:45Z","timestamp":1785562185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jprs\/5\/4\/5_2025-0068\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.53045\/jprs.2025-0068","relation":{},"ISSN":["2436-259X"],"issn-type":[{"value":"2436-259X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"article-number":"2025-0068"}}